General Information of DTT (ID: TT38MDJ)

DTT Name Tissue factor (F3) DTT Info
Gene Name F3

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tisotumab vedotin DMF8FK3 Cervical cancer 2C77.0 Approved [1]
------------------------------------------------------------------------------------
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ALT-836 DMGJ71F Adult respiratory distress syndrome CB00 Phase 2 [2]
TT-173 DMSIXG4 Bleeding disorder GA20-GA21 Phase 2 [3]
MORAb-066 DMTUKW9 Pancreatic cancer 2C10 Phase 1 [4]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
D-Pro-Phe-Arg chloromethyl ketone DMRJQ8X Discovery agent N.A. Investigative [5]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 FDA Approved Drug Products from FDA Official Website. 2021. Application Number: 761208.
2 ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment. Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1295-303.
3 TETIS study: evaluation of new topical hemostatic agent TT-173 in tooth extraction. Clin Oral Investig. 2016 Jun;20(5):1055-63.
4 Clinical pipeline report, company report or official report of Morphotek.
5 Novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors. J Med Chem. 2008 Jun 12;51(11):3077-80.